Big Pharma believes that a global generics franchise might give it a softer landing off the patent cliff, but governments that sponsor and regulate the industry are still acting a bit slow on the uptake. The reason? Anti-IP activists are again poisoning the well on global access to medicines, engaging the bigger emerging market governments [...]
PharmExec Blog
Follow Us
RSS
Bookstore
WHO Threatens Industry Shut-out on Counterfeit Regulation